Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Cerebral Venous Thrombosis in Argentina: Clinical Characteristics, Epidemiology, Prognosis and Treatment
Cerebrovascular Disease and Interventional Neurology
P10 - Poster Session 10 (5:30 PM-6:30 PM)
4-003
 Our objective was to assess the characteristics of CVT on patients from our center. 
Cerebral venous thrombosis (CVT) is an uncommon and severe disease that affects mainly women and has a mortality rate of 5%. Since there is no information available in our country regarding this disease

All consecutive patients with a diagnosis of CVT from August 1990 to October 2017 were analyzed. We assessed clinical, epidemiological and imaging characteristics. Data were presented as percentages for categorical variables and as mean for quantitative variables. For analysis, Fisher and Mann-Whitney tests were used as appropriate. A p<0.05 (two-tailed test) was considered significant.

We included 53 patients, age: 37.7 years (range: 18-85); 73.1% were women. The most frequent risk factor was arterial hypertension in 42% (p<0.01) of men, and hormonal disorders in 44% (p <0.01) of women. Most common symptoms of presentation: headache in 74% and motor symptoms in 40%. Ninety-two percent of the patients received anticoagulation as treatment. Follow-up time was 5.15 years (range: 2 months - 21 years). Complications: 18% of patients developed epilepsy and/or chronic headache.
Most of our CVT patients were women, and received treatment with anticoagulation. The prognosis was generally favorable and no deaths were observed. This is the first study analyzing clinical characteristics, epidemiology, complications, prognosis, and treatment of CVT in our country. Given the ethnic and lifestyle differences observed between countries, we consider worthy to explore these variables in our population.
Authors/Disclosures

PRESENTER
No disclosure on file
No disclosure on file
No disclosure on file
Lucrecia Bandeo Lucrecia Bandeo has nothing to disclose.
Anibal Chertcoff (University of British Columbia) Anibal Chertcoff has nothing to disclose.
Marcela Uribe Roca (Hospital De Clinicas) The institution of Marcela Uribe Roca has received research support from Roche.
Pablo Bonardo, MD Dr. Bonardo has nothing to disclose.
Oscar Martinez, MD No disclosure on file
Luciana V. Leon Cejas, MD (Hospital Britanico) Dr. Leon Cejas has nothing to disclose.
Maria S. Pacha No disclosure on file
Ricardo C. Reisin, MD (Hospital Britanico) Dr. Reisin has nothing to disclose.